Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Common Equity (2016 - 2025)

Icu Medical (ICUI) has disclosed Common Equity for 17 consecutive years, with $2.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 8.07% year-over-year to $2.1 billion, compared with a TTM value of $2.1 billion through Dec 2025, up 8.07%, and an annual FY2025 reading of $2.1 billion, up 8.07% over the prior year.
  • Common Equity was $2.1 billion for Q4 2025 at Icu Medical, roughly flat from $2.1 billion in the prior quarter.
  • Across five years, Common Equity topped out at $2.2 billion in Q1 2022 and bottomed at $1.5 billion in Q1 2021.
  • Average Common Equity over 5 years is $2.0 billion, with a median of $2.1 billion recorded in 2022.
  • The sharpest move saw Common Equity skyrocketed 43.28% in 2022, then fell 7.45% in 2024.
  • Year by year, Common Equity stood at $1.6 billion in 2021, then grew by 29.32% to $2.1 billion in 2022, then grew by 1.6% to $2.1 billion in 2023, then fell by 7.45% to $2.0 billion in 2024, then rose by 8.07% to $2.1 billion in 2025.
  • Business Quant data shows Common Equity for ICUI at $2.1 billion in Q4 2025, $2.1 billion in Q3 2025, and $2.1 billion in Q2 2025.